Latest News and Press Releases
Want to stay updated on the latest news?
-
Quarterly investor call and webcast scheduled on Monday, November 15th at 8:00am ETRoivant will also present at the Jefferies London Healthcare and Evercore ISI HealthCONx investor conferences in...
-
Roivant will begin trading on Nasdaq under the ticker “ROIV” later todayR&D Day presentations from September 28th highlighting Roivant’s pipeline and discovery platform available on Roivant’s...
-
-Roivant intends to commence Phase 3 clinical trials in Alzheimer's disease in 2015- -Development led by the developer of Alzheimer's medicine, Aricept- HAMILTON, Bermuda, Dec. 23, 2014 (GLOBE...